Cite
HARVARD Citation
Epstein-Peterson, Z. et al. (2022). De Novo myelodysplastic syndromes in patients 20–50 years old are enriched for adverse risk features. Leukemia research. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Epstein-Peterson, Z. et al. (2022). De Novo myelodysplastic syndromes in patients 20–50 years old are enriched for adverse risk features. Leukemia research. p. . [Online].